We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cordless Handheld Device Uses Vibrations to Eliminate Fingerstick Pain for Blood Sugar Testing

By LabMedica International staff writers
Posted on 10 Nov 2021

A new portable tool uses innovative vibration technology to improve the ease of diabetes management. More...

BING Innovations, LLC (Boca Raton, FL, USA) has launched DigiVibe, a cordless handheld device that uses vibrations to eliminate the pain of getting the finger pricked. Specifically designed for blood glucose monitoring, DigiVibe applies vibration directly to the finger, blocking pain signals to the brain and helping to make the process more tolerable for both children and adults.

While many people only get their finger-pricked at their annual checkup, for those with diabetes, glucose monitoring means having to prick their finger three or more times each day. DigiVibe, an FDA-registered and CE-certified device, has been created to reduce the pain and anxiety of checking glucose levels, whether a person is not keen on needles or just weary of repeated finger pricks. The easy-to-use and portable device adheres to any flat surface for hands-free use, making self-testing and diabetes management easier and more convenient than ever before. For a doctor who regularly deals with diabetic patients or an individual who must test their glucose levels regularly, the DigiVibe device can make the process easier and virtually painless - in as little as 12 seconds.

The DigiVibe Starter Kit includes a sleek carrying case containing one DigiVibe device, stand and tip, lancing device, five 30-gauge lancets, and one AA lithium battery. The battery is designed to last for approximately three months or roughly 450 finger sticks for a single user. Plus, there is enough space in the carrying case to fit one’s regular test strips and glucose testing device. Additional accessories or refills of supplies can also be ordered anytime on the DigiVibe website. One-time use disposable tips and lancing devices are also available for medical practitioners.

"The conventional way to test blood sugar for diabetes is often associated with pain, discomfort, and even fear, but DigiVibe has set out to dramatically make this experience better," said Dr. Marcelo Bendix, Endocrinologist and DigiVibe Medical Advisor. "Pain and finger soreness are among the top reasons diabetics sometimes skip blood glucose testing, which is not only dangerous, but makes it quite difficult for them to effectively manage diabetes. DigiVibe is truly a game-changer; it will allow patients to stay on top of their glucose testing and no longer fear the dreaded finger-prick they have to endure in the doctor's office and at home."

Related Links:
BING Innovations, LLC 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Urine Analyzer
respons® UDS100
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.